Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1976 4
1978 1
1980 1
1981 1
1982 1
1983 1
1984 3
1985 2
1986 2
1987 1
1988 1
1989 2
1990 3
1991 3
1992 5
1993 4
1994 4
1995 2
1996 10
1997 6
1998 13
1999 11
2000 6
2001 5
2002 7
2003 6
2004 6
2005 15
2006 12
2007 11
2008 13
2009 14
2010 15
2011 10
2012 20
2013 21
2014 19
2015 18
2016 20
2017 22
2018 16
2019 18
2020 23
2021 18
2022 14
2023 13
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

391 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Anemia due to Decreased Production"
Page 1
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Lancet. 2018 Nov 10;392(10159):1789-1858. doi: 10.1016/S0140-6736(18)32279-7. Epub 2018 Nov 8. Lancet. 2018. PMID: 30496104 Free PMC article.
We used DisMod-MR 2.1, a Bayesian meta-regression tool, as the main method of estimation, ensuring consistency between rates of incidence, prevalence, remission, and cause of death for each condition. YLDs were estimated as the product of a prevalence estimate and a disabi …
We used DisMod-MR 2.1, a Bayesian meta-regression tool, as the main method of estimation, ensuring consistency between rates of incidence, p …
Chronic Kidney Disease.
Webster AC, Nagler EV, Morton RL, Masson P. Webster AC, et al. Lancet. 2017 Mar 25;389(10075):1238-1252. doi: 10.1016/S0140-6736(16)32064-5. Epub 2016 Nov 23. Lancet. 2017. PMID: 27887750 Review.
The definition and classification of chronic kidney disease (CKD) have evolved over time, but current international guidelines define this condition as decreased kidney function shown by glomerular filtration rate (GFR) of less than 60 mL/min per 1.73 m(2), or markers of k …
The definition and classification of chronic kidney disease (CKD) have evolved over time, but current international guidelines define this c …
Current status of beta-thalassemia and its treatment strategies.
Ali S, Mumtaz S, Shakir HA, Khan M, Tahir HM, Mumtaz S, Mughal TA, Hassan A, Kazmi SAR, Sadia, Irfan M, Khan MA. Ali S, et al. Mol Genet Genomic Med. 2021 Dec;9(12):e1788. doi: 10.1002/mgg3.1788. Epub 2021 Nov 5. Mol Genet Genomic Med. 2021. PMID: 34738740 Free PMC article. Review.
BACKGROUND: Thalassemia is an inherited hematological disorder categorized by a decrease or absence of one or more of the globin chains synthesis. ...The absence or reduced amount of beta-globin chains causes ineffective erythropoiesis which leads to anemia. METHODS …
BACKGROUND: Thalassemia is an inherited hematological disorder categorized by a decrease or absence of one or more of the globin chai …
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Lancet. 2017 Sep 16;390(10100):1211-1259. doi: 10.1016/S0140-6736(17)32154-2. Lancet. 2017. PMID: 28919117 Free PMC article.
For some causes, we used alternative modelling strategies if incidence or prevalence needed to be derived from other data. YLDs were estimated as the product of prevalence and a disability weight for all mutually exclusive sequelae, corrected for comorbidity and aggregated …
For some causes, we used alternative modelling strategies if incidence or prevalence needed to be derived from other data. YLDs were estimat …
Anemia in thyroid diseases.
Szczepanek-Parulska E, Hernik A, Ruchała M. Szczepanek-Parulska E, et al. Pol Arch Intern Med. 2017 May 31;127(5):352-360. doi: 10.20452/pamw.3985. Epub 2017 Mar 28. Pol Arch Intern Med. 2017. PMID: 28400547 Free article. Review.
Thus, different forms of anemia might develop in the course of thyroid dysfunction. Normocytic anemia is the most common, while macrocytic or microcytic anemia occurs less frequently. Anemia in hypothyroidism might result from bone marrow depres …
Thus, different forms of anemia might develop in the course of thyroid dysfunction. Normocytic anemia is the most commo …
An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma.
Izutsu K, Makita S, Nosaka K, Yoshimitsu M, Utsunomiya A, Kusumoto S, Morishima S, Tsukasaki K, Kawamata T, Ono T, Rai S, Katsuya H, Ishikawa J, Yamada H, Kato K, Tachibana M, Kakurai Y, Adachi N, Tobinai K, Yonekura K, Ishitsuka K. Izutsu K, et al. Blood. 2023 Mar 9;141(10):1159-1168. doi: 10.1182/blood.2022016862. Blood. 2023. PMID: 36150143 Free PMC article. Clinical Trial.
Adult T-cell leukemia/lymphoma (ATL) is an aggressive non-Hodgkin lymphoma with poor prognosis and few treatment options for patients with relapsed, recurrent, or refractory disease. ...TEAEs that occurred in 20% of patients included thrombocytopenia, anemia, alopec …
Adult T-cell leukemia/lymphoma (ATL) is an aggressive non-Hodgkin lymphoma with poor prognosis and few treatment options for patients …
Blood Product Transfusion in Adults: Indications, Adverse Reactions, and Modifications.
Raval JS, Griggs JR, Fleg A. Raval JS, et al. Am Fam Physician. 2020 Jul 1;102(1):30-38. Am Fam Physician. 2020. PMID: 32603068 Free article.
Transfusion of plasma corrects clinically significant coagulopathy in patients with or at high risk of bleeding. Mildly abnormal laboratory coagulation values are not predictive of clinical bleeding and should not be corrected with plasma. ...Modifications to blood product …
Transfusion of plasma corrects clinically significant coagulopathy in patients with or at high risk of bleeding. Mildly abnormal laboratory …
Global, Regional, and National Burden of Diabetes-Related Chronic Kidney Disease From 1990 to 2019.
Deng Y, Li N, Wu Y, Wang M, Yang S, Zheng Y, Deng X, Xiang D, Zhu Y, Xu P, Zhai Z, Zhang D, Dai Z, Gao J. Deng Y, et al. Front Endocrinol (Lausanne). 2021 Jul 1;12:672350. doi: 10.3389/fendo.2021.672350. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34276558 Free PMC article.
Age-standardized incidence (ASIR) and prevalence rate (ASPR) of type 1 diabetes-related CKD increased, whereas age-standardized death rate (ASDR) and DALY rate decreased for females and increased for males. In high SDI quintile, ASIR and ASPR of type 1 diabetes-related CKD …
Age-standardized incidence (ASIR) and prevalence rate (ASPR) of type 1 diabetes-related CKD increased, whereas age-standardized death rate ( …
Pembrolizumab-induced agranulocytosis.
Fernández Martínez V, García-Avello Fernández-Cueto A, Valencia Soto CM, Barbadillo Villanueva S, Ochagavía Sufrategui M, Rioja Carrera M, Alonso Buznego LA, Valero Domínguez M. Fernández Martínez V, et al. J Oncol Pharm Pract. 2024 Jun;30(4):767-771. doi: 10.1177/10781552241228774. Epub 2024 Jan 30. J Oncol Pharm Pract. 2024. PMID: 38291678
MANAGEMENT AND OUTCOME: Pembrolizumab was discontinued immediately. Grade 4 neutrophil decrease is mentioned in the product information sheet as a rare side effect. The patient was admitted in poor physical condition with grade 4 neutropenic fever, mucositis and …
MANAGEMENT AND OUTCOME: Pembrolizumab was discontinued immediately. Grade 4 neutrophil decrease is mentioned in the product in …
Global burden of sickle cell anaemia in children under five, 2010-2050: modelling based on demographics, excess mortality, and interventions.
Piel FB, Hay SI, Gupta S, Weatherall DJ, Williams TN. Piel FB, et al. PLoS Med. 2013;10(7):e1001484. doi: 10.1371/journal.pmed.1001484. Epub 2013 Jul 16. PLoS Med. 2013. PMID: 23874164 Free PMC article.
BACKGROUND: The global burden of sickle cell anaemia (SCA) is set to rise as a consequence of improved survival in high-prevalence low- and middle-income countries and population migration to higher-income countries. ...It is likely that Nigeria (2010: 91,000 newborns with …
BACKGROUND: The global burden of sickle cell anaemia (SCA) is set to rise as a consequence of improved survival in high-prevalence lo …
391 results